Professor and Vice Chair of Research, Ricardo Battaglino, PhD, teamed up with fellow U colleagues to study the use of apilimod in treating COVID-19. Early results, using cell culture work, show that the drug is five times more effective than remdesivir.

Dr. Battaglino is the co-director of the Rehabilitation Medicine Translational Research Lab along with Department Head, Leslie Morse, DO. 

Read the full article